Insights into Chagas treatment based on the potential of bacteriocin AS-48

Chagas disease caused by the protozoan parasite Trypanosoma cruzi represents a significant public health problem in Latin America, affecting around 8 million cases worldwide. Nowadays is urgent the identification of new antichagasic agents as the only therapeutic options available, Nifurtimox and Be...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Escolano, Rubén, Cebrián, Rubén, Martín-Escolano, Javier, Rosales, Maria J., Maqueda, Mercedes, Sánchez-Moreno, Manuel, Marín, Clotilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447751/
https://www.ncbi.nlm.nih.gov/pubmed/30953804
http://dx.doi.org/10.1016/j.ijpddr.2019.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447751/
https://www.ncbi.nlm.nih.gov/pubmed/30953804
http://dx.doi.org/10.1016/j.ijpddr.2019.03.003

Ejemplares similares